TITLE

Out of Pfizer's Shadow

AUTHOR(S)
Kelly, Tim; Orr, Deborah
PUB. DATE
April 2007
SOURCE
Forbes Asia;4/23/2007, Vol. 3 Issue 7, p28
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the success of the Japanese pharmaceutical firm Eisai in the U.S. market. Worldwide sales of its Aricept and Aciphex drugs accounted for 54 percent of its $5 billion revenue for the year ending March 2006. Chief Executive Officer Haruo Eisa Naito expects net profit to double to $1 billion. The company plans to double its U.S. sales team to 1,500 people. Due to its success in the U.S., the company is planning to terminate its marketing deal with Pfizer.
ACCESSION #
25030753

 

Related Articles

  • COMPANY SPOTLIGHT -- Eisai Co., Ltd.  // PharmaWatch: Cancer;Dec2006, Vol. 5 Issue 12, p16 

    No abstract available.

  • Company Overview.  // Eisai Co., Ltd. SWOT Analysis;Jan2005, p4 

    Presents an overview of Eisai Co. Ltd., Tokyo, Japan-based company, which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives. Revenues generated in fiscal year 2005; Principal business offered, including manufacturing and...

  • Key Facts.  // Eisai Co., Ltd. SWOT Analysis;Jan2005, p4 

    Presents key facts about Eisai Co. Ltd., Tokyo, Japan-based company, which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives. Address and contact information; Revenues and financial year end data; Number of employees; SIC...

  • Eisai Co., Ltd. SWOT Analysis.  // Eisai Co., Ltd. SWOT Analysis;Jan2005, p1 

    Presents an overview of Eisai Co. Ltd., Tokyo, Japan-based company, which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives. Company overview, including revenues generated in fiscal year 2005, services provided, and...

  • Eisai Co., Ltd. SWOT Analysis.  // Eisai Co., Ltd. SWOT Analysis;January 2004, p1 

    Presents an overview of Eisai Co. Ltd., a company which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives. Company overview, including revenues generated in fiscal year 2003, services provided, and principal businesses;...

  • Company Overview.  // Eisai Co., Ltd. SWOT Analysis;January 2004, p4 

    Presents an overview of Eisai Co. Ltd., a company which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives. Revenues generated in fiscal year 2003, Principal business offered including ethical drugs and diagnostic business.

  • Key Facts.  // Eisai Co., Ltd. SWOT Analysis;January 2004, p4 

    Presents key facts about Eisai Co. Ltd., a company which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives. Address and contact information; Revenues and financial year end data; Number of employees; SIC and NAICS codes;...

  • SWOT Analysis.  // Eisai Co., Ltd. SWOT Analysis;January 2004, p5 

    Provides a business analysis of Eisai Co. Ltd., a company which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths,...

  • SWOT Analysis.  // Eisai Co., Ltd. SWOT Analysis;Jan2005, p5 

    Provides a business analysis of Eisai Co. Ltd., Tokyo, Japan-based company, which specializes in the manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs, and chemical/food additives, focusing on its strengths, weaknesses, opportunities for improvement and threats to the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics